Published in Am J Med on October 01, 1991
Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum (2009) 2.50
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis (2007) 1.69
Disparities in lupus care and outcomes. Curr Opin Rheumatol (2009) 1.45
Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum (2009) 1.42
Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence. J Rheumatol (2015) 1.40
Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med (2006) 1.34
Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol (2008) 1.29
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus. Ann Rheum Dis (2007) 1.28
The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol (2008) 1.25
Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus. J Rheumatol (2010) 0.99
Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation. Ann Rheum Dis (1992) 0.95
PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One (2013) 0.91
Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis. Arthritis Rheumatol (2016) 0.86
Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement. Arthritis Care Res (Hoboken) (2013) 0.86
Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Hum Mol Genet (2013) 0.85
[Changes in mortality and morbidity in systemic lupus erythematosus]. Z Rheumatol (2011) 0.85
Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis (2000) 0.83
Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study. Lupus Sci Med (2014) 0.83
Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. J Natl Med Assoc (1999) 0.83
Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol (2013) 0.83
Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE. Genes Immun (2009) 0.82
Geographical Clustering of Juvenile Onset Systemic Lupus Erythematosus within the Sultanate of Oman. Oman Med J (2013) 0.81
Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2015) 0.80
Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort. J Clin Cell Immunol (2014) 0.78
Healthcare quality in systemic lupus erythematosus: using Donabedian's conceptual framework to understand what we know. Int J Clin Rheumtol (2012) 0.78
Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus. J Rheumatol (2012) 0.78
The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol (2016) 0.77
Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort. Lupus (2013) 0.77
Increased risk of death in African American patients with end-stage renal disease secondary to lupus. Clin Kidney J (2014) 0.77
Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. Clin Rheumatol (2012) 0.77
Preventive health services for systemic lupus erythematosus patients: whose job is it? Arthritis Res Ther (2010) 0.77
Severe systemic lupus erythematosus in emergency department: a retrospective single-center study from China. Clin Rheumatol (2011) 0.76
Frequency of Lost to Follow-Up and Associated Factors for Patients with Rheumatic Diseases. PLoS One (2016) 0.76
A retrospective analysis of clinical presentation of lupus nephritis. Am J Med Sci (2011) 0.75
The impact of rural residency on the expression and outcome of systemic lupus erythematosus: data from a multiethnic Latin American cohort. Lupus (2012) 0.75
Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study. Lupus Sci Med (2015) 0.75
Why targeted therapies are necessary for systemic lupus erythematosus. Lupus (2016) 0.75
Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients. Eur J Rheumatol (2017) 0.75
Translating epigenetics into clinic: focus on lupus. Clin Epigenetics (2017) 0.75
Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region. Rheumatol Int (2016) 0.75
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum (1986) 29.12
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage (1995) 7.18
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
Harnessing optical forces in integrated photonic circuits. Nature (2008) 2.90
Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis (2004) 2.89
Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med (2000) 2.46
Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med (1992) 2.39
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage (2006) 2.01
Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum (1991) 1.99
Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum (2001) 1.91
Knee pain and knee osteoarthritis severity in self-reported task specific disability: the Johnston County Osteoarthritis Project. J Rheumatol (1997) 1.71
Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J Immunol (1984) 1.69
Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol (1998) 1.65
Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64
Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev (2003) 1.63
A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee. Rheumatology (Oxford) (1999) 1.60
Antibodies to RNA from autoimmune NZB/NZW mice recognize a similar antigenic determinant and show a large idiotypic diversity. Proc Natl Acad Sci U S A (1982) 1.58
Radiographically defined osteoarthritis of the hand and knee in young and middle-aged African American and Caucasian women. Osteoarthritis Cartilage (2000) 1.55
A decision analysis of mandatory compared with voluntary HIV testing in pregnant women. Ann Intern Med (1998) 1.53
Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum (1991) 1.52
Low back pain and disability in older women: independent association with difficulty but not inability to perform daily activities. J Gerontol A Biol Sci Med Sci (1999) 1.44
Emergency operation after failed angioplasty. J Thorac Cardiovasc Surg (1988) 1.44
Clinical decisions in the use of acupuncture as an adjunctive therapy for osteoarthritis of the knee. Altern Ther Health Med (2001) 1.44
Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups. Rheumatology (Oxford) (2001) 1.41
Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthritis Cartilage (2003) 1.41
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40
Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol (1998) 1.36
Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation (2000) 1.35
OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage (2009) 1.30
Incidence of lung cancer in systemic sclerosis. J Rheumatol (1985) 1.22
Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. Osteoarthritis Cartilage (2006) 1.19
Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis Cartilage (2008) 1.15
Photodetection in silicon beyond the band edge with surface states. Opt Express (2008) 1.15
Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group. Osteoarthritis Cartilage (2004) 1.12
The experience of pain and emergent osteoarthritis of the knee. Osteoarthritis Cartilage (2001) 1.11
Low-energy distal radius fractures in middle-aged and elderly women-seasonal variations, prevalence of osteoporosis, and associates with fractures. Osteoporos Int (2009) 1.06
Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol (2001) 1.05
Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol (1992) 1.05
The natural history of emergent osteoarthritis of the knee in women. Osteoarthritis Cartilage (2002) 1.05
Acetabular dysplasia and osteoarthritis of the hip in elderly white women. Ann Rheum Dis (1997) 1.00
Collagenous colitis, enteropathic arthritis, and autoimmune diseases: results of a patient survey. J Rheumatol (1989) 1.00
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) (1984) 1.00
Articular hypermobility is a protective factor for hand osteoarthritis. Arthritis Rheum (2004) 0.99
Infliximab for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev (2002) 0.98
Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev (2000) 0.98
Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. Am J Epidemiol (1996) 0.96
The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene (2006) 0.95
Early detection of radiographic knee osteoarthritis using computer-aided analysis. Osteoarthritis Cartilage (2009) 0.94
Coxibs and NSAIDs--is the air any clearer? Perspectives from the OARSI/International COX-2 Study Group Workshop 2007. Osteoarthritis Cartilage (2007) 0.91
One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) (1995) 0.90
Optical modulation and detection in slotted Silicon waveguides. Opt Express (2005) 0.90
The VH gene sequences of anti-DNA antibodies in two different strains of lupus-prone mice are highly related. Eur J Immunol (1989) 0.86
Monoclonal autoantibodies to histones from autoimmune NZB/NZW F1 mice. Eur J Immunol (1984) 0.86
Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage (2008) 0.85
A four-year experience with preoperative noninvasive carotid evaluation of two thousand twenty-six patients undergoing cardiac surgery. J Vasc Surg (1984) 0.85
Relationship between health status and utility measures in older claudicants. Qual Life Res (1998) 0.84
Demonstration of a low V pi L modulator with GHz bandwidth based on electro-optic polymer-clad silicon slot waveguides. Opt Express (2010) 0.84
Erythropoietin response to anemia as a function of age. J Am Geriatr Soc (1991) 0.84
Variation by specialty in the treatment of urinary tract infection in women. J Gen Intern Med (1999) 0.83
Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine (Baltimore) (1993) 0.83
Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients. Clin Nephrol (2004) 0.82
Alignment of the medial tibial plateau affects the rate of joint space narrowing in the osteoarthritic knee. Osteoarthritis Cartilage (2010) 0.82
Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol (1990) 0.82
Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. Biochim Biophys Acta (1995) 0.82
Hair product use in systemic lupus erythematosus. A case-control study. Arthritis Rheum (1992) 0.81
The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol (1993) 0.79
[Cutaneous leishmaniasis]. Hautarzt (2003) 0.78
Molecular characterization of an unusual non-Hodgkin's B-lymphoma cell line ("Farage") lacking the ability to produce immunoglobulin polypeptide chains. Leuk Lymphoma (1996) 0.76
Photoprotection by Cichorum endivia extracts: prevention of UVB-induced erythema, pyrimidine dimer formation and IL-6 expression. Skin Pharmacol Physiol (2004) 0.76
Meralgia paresthetica after coronary bypass surgery. J Thorac Cardiovasc Surg (1991) 0.75
Treatment for acquired palatal openings. Gen Dent (1986) 0.75
How physicians diagnose urinary tract infections: the potential influence of laboratory regulations on test availability and use. J Fam Pract (2001) 0.75
Anti-Ro antibodies and neonatal lupus. Rheum Dis Clin North Am (1989) 0.75
Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™. Osteoporos Int (2015) 0.75